Article Information
History
- April 6, 2021.
Article Versions
- Version 1 (January 25, 2021 - 07:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aimee M. Deaton1,#,
- Margaret M. Parker1,
- Lucas D. Ward1,
- Alexander O. Flynn-Carroll1,
- Lucas BonDurant1,
- Gregory Hinkle1,
- Parsa Akbari2,
- Luca A. Lotta2,
- Regeneron Genetics Center2,*,
- DiscovEHR Collaboration3,
- Aris Baras2 and
- Paul Nioi1
- 1Alnylam Pharmaceuticals, Cambridge, MA
- 2Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY
- 3Geisinger Health System, Danville, PA
- ↵#Corresponding author; email: adeaton{at}alnylam.com
↵* For full author and contribution list see Supplementary Information.